Increasing HAART-Induced Immune Restoration With Cyclosporine

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 2006

Conditions
HIV Infections
Interventions
DRUG

Abacavir sulfate, Lamivudine and Zidovudine

DRUG

Cyclosporine

BIOLOGICAL

Hepatitis A Vaccine (Inactivated)

DRUG

Efavirenz

BIOLOGICAL

Pneumococcal Conjugate Vaccine, Heptavalent

BIOLOGICAL

Rabies Vaccine

Trial Locations (15)

19104

University of Pennsylvania, Philadelphia, Philadelphia

21201

University of Maryland, Institute of Human Virology, Baltimore

27599

Univ of North Carolina / Infectious Disease Division, Chapel Hill

44106

Case Western Reserve Univ, Cleveland

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

63108

Washington Univ (St. Louis), St Louis

75390

Univ of Texas Southwestern Med Ctr, Dallas

Univ of Texas, Southwestern Med Ctr of Dallas, Dallas

95814

University of California , Davis Medical Center, Sacramento

441091998

MetroHealth Med Ctr, Cleveland

606123832

Rush Presbyterian - Saint Luke's Med Ctr / Infect Dis, Chicago

33136-1013

University of Miami, Miami

46202-5250

Indiana University Hospital, Indianapolis

55455-0392

Univ of Minnesota, Minneapolis

27599-7215

Univ of North Carolina, Chapel Hill

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH